Product Datasheet
|
|
|
Product Description |
|
Product: |
Ceruloplasmin, Human Plasma |
Catalog Number: |
HCP |
Product Page: |
https://www.mol-innov.com/products/ |
Description: |
An acute-phase reactant. Increased levels are associated with normal pregnancy, rheumatoid arthritis, and cirrhosis. Decreased levels are associated with hepatolenticular degeneration (Wilson's Disease). An elevated level of Cp is found in patients with progressive tumors. Additionally, as Cp is a prooxidant, an elevated level is a sign of cardiovascular disease. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion. |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
232.75 |
Source: |
Lyophilized |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
132,000 |
Antigen: |
-70 C |
Target: |
Lyophilized powder |
Target Molecular Weight: |
HUMAN PLASMA PROTEINS |
Host: |
755.25 |
Clonality: |
5 |
Isotype: |
Human plasma |
Clone: |
s |
Applications: |
Cold pack |
Cross-reactivity: |
3 years from delivery |
Concentration: |
245 |
Volume: |
795 |
Titer: |
0.05M Sodium Phosphate; 0.1M KCl; 0.005M EDTA; 0.02M EACA; pH 6.8 |
Buffer: |
SAMPLE |
Form: |
1.0 mg |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |